THE RAPID PRODUCTION OF ANTIDYSENTERIC SERUM
The Journal of Experimental Medicine
|October 30, 2009
Summary
Researchers developed a safe and effective method for preparing antidysenteric serum in horses. This polyvalent serum, targeting both Shiga and Flexner dysentery strains, can be ready for therapeutic use in approximately ten weeks.
Area of Science:
- Immunology
- Microbiology
- Veterinary Medicine
Background:
- Bacillary dysentery remains a significant public health concern, necessitating effective therapeutic interventions.
- The development of potent antidysenteric serum is crucial for combating infections caused by various *Shigella* species.
Purpose of the Study:
- To establish a safe and efficient protocol for producing high-titer polyvalent antidysenteric serum in horses.
- To evaluate the immunogenicity and therapeutic potential of the prepared serum against acute bacillary dysentery.
Main Methods:
- Horses were immunized with three successive intravenous injections of living *Shigella* cultures or toxins, with seven-day intervals.
- Alternating inoculation with Shiga and Flexner *Shigella* strains generated a polyvalent immune response.
Main Results:
- Specific antibodies for agglutination and protection appeared early and increased rapidly following immunization.
- A polyvalent serum with a high titer was successfully prepared, indicating broad efficacy.
- The immunization process was completed within approximately ten weeks.
Conclusions:
- The described immunization method is safe and effective for producing high-titer antidysenteric serum in horses.
- The resulting polyvalent serum is suitable for the therapeutic treatment of acute bacillary dysentery, regardless of the infecting *Shigella* strain.
- This approach offers a timely and viable solution for producing essential therapeutic agents against dysentery.
More Related Videos
09:12A Protein Microarray Assay for Serological Determination of Antigen-specific Antibody Responses Following Clostridium difficile Infection
Published on: June 15, 2018
07:04Optimization of Antigen Preparation for Hemagglutination Inhibition Assay of Newcastle Disease Virus Serology
Published on: January 24, 2025
